hallucinations/cannabis

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 92 rezilta yo

A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cannabis, the most widely used illicit drug, can induce hallucinations. Our understanding of the biology of cannabis-induced hallucinations (Ca-HL) is limited. We used the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) to identify cannabis-induced hallucinations (Ca-HL) among

"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Introduction: Cannabis has been historically classified as a hallucinogen. However, subjective cannabis effects do not typically include hallucinogen-like effects. Empirical reports of hallucinogen-like effects produced by cannabis in controlled settings, particularly among healthy research

COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE A functional polymorphism in the catechol-o-methyltransferase gene (COMT Val(158)Met) may moderate the psychosis-inducing effects of cannabis. In order to extend this finding to dynamic effects in the flow of daily life, a momentary assessment study of psychotic symptoms in response to

Human EEG spectra before and during cannabis hallucinations.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

EEG correlates of subjective experiences induced by delta9-trans-tetrahydrocannabinol (THC) and EEG correlates of individual disposition to such experiences were investigated. Twelve normal volunteers took 200 mug/kg THC orally. The subjects were asked to signal subjective experiences. The EEG was

[Neurobiology of endocannabinoids and central effects of tetrahydrocannabinol contained in indian hemp].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tetrahydrocannabinol, the main psychotropic component of Cannabis indica, is an addictive drug with multiple effects including both peripheral and central damages. All these effects are due to interference with endocannabinoidergic transmission. This endocannabinoid system subtly regulates many

Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Synthetic cannabinoid receptor agonists (SCRAs) are suggested to have increased potential to induce psychosis compared to natural cannabis (NC). In this review we synthesise current knowledge about the association of SCRA use with psychotic symptoms. Following a literature search we identified 2

Acute Liver Injury Induced by Synthetic Cannabinoid Abuse.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Synthetic cannabinoid abuse can manifest with an array of unpredictable reactions ranging from sedation to hallucinations, psychosis, and seizures. Acute liver injury associated with the synthetic cannabinoid use is a rare complication. We present a case of a 22-year-old homeless male presented with

Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Synthetic Cannabinoid Receptor Agonists (SCRAs) are the largest group of new psychoactive substances reported to the European Warning System and the United Nations Office on Drugs and Crime to date. The heterogeneous nature and speed of diversification of these compounds make it challenging to

Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cannabis use and the development of schizophrenic psychoses share a variety of similarities. Both start during late adolescence; go along with neuropsychological deficits, reduced activity, motivation deficits, and hallucinations suggesting impairment of similar brain structures. In cannabis heavy

The clinical toxicology of cannabis

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cannabis is one of the most widely used recreational drugs in the world. Tetrahydrocannabinol (THC) is the psychoactive principal constituent of the cannabis plant (Cannabis sativa). It is taken either orally or by inhalation, resulting in sedation, euphoria, relaxation and loss of social

[Cannabinoid and cathinone designer drugs - the workings and selected methods of analysis].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Recently, there has been an increase in the consumption of designer drugs, substances aimed at producing psychoactive, energizing, euphoric or anesthetic effects. Designer drugs are substitutes of actual narcotics, whose possession is banned under Polish law according to the Act of 29 July 2005. The

Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

General population epidemiological studies have consistently found that cannabis use increases the risk of developing psychotic disorders in a dose-dependent manner. While the epidemiological signal between cannabis and psychosis has gained considerable attention, the biological mechanism whereby

A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The use of synthetic cannabinoids is being increasingly recognised worldwide, but the chemical compositions and physiological effects of these drugs are poorly characterised and are continually changing. New substances are constantly being added to the content of synthetic cannabinoids and they are

Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cannabis users are more likely to have psychotic experiences (PEs). The degree to which these associations are driven by genetic or environmental influences in adolescence is unknown. This study estimated the genetic and environmental contributions to the relationship between cannabis use and PEs.

Is cannabis a risk factor for suicide attempts in men and women with psychotic illness?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To investigate whether recent cannabis use by men and women with psychotic disorders was associated with increased risk of suicide attempt, and to determine associated factors, stratified by sex. METHODS Data from 1065 men and 725 women interviewed in the Australian national survey of

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye